The influenza diagnostics market is expected to grow at a CAGR of 7.9% from 2020 to 2027 to reach at $1.17 billion by 2027. Influenza which is commonly known as “the flu”, is an infectious disease caused by an influenza virus. It is spread in all population more specifically in people with weak immune response. […]Read More..
An immunoassay is a chemical test used to detect or quantify a specific substance using an immunological reaction. Immunoassays are utilized in healthcare industry in diagnostics applications, such as infectious diseases, endocrinology, oncology, bone & mineral disorders, cardiology, hematology & blood screening, autoimmune disorders, neonatal screening, and in toxicology testing. In 2019, the global immunoassays […]Read More..
Growth of global IVD market is driven by rising geriatric population and subsequent growth in the prevalence of chronic and infectious diseases, increasing adoption of fully automated instruments and automation in laboratories, and growing adoption of personalized medicine and point-of-care testing. Development of condition-specific markers and tests and growing demand for IVD products in emerging […]Read More..
The global NGS services market is expected to reach USD 13.1 billion by 2025 supported by a CAGR of 20.5% during the forecast period of 2019 to 2025, says “Meticulous Research”. The field of genomics has surpassed expectations over the past three decades due to massive changes in technology that allowed researchers to interrogate larger […]Read More..
With the growing need to achieve better value for healthcare, the importance of real-world evidence (RWE) as a decision-making tool and an important part of drug development and commercialization has also raised. Pharma and biopharma companies now recognize the need to get a better understanding and stronger evidence of product performance, clinical value and cost […]Read More..
The Global Patient Registry Software Market is expected to grow at a CAGR of 11.0% from 2018 to 2023 to reach USD 1.49 billion by 2023. With growing efforts for the adoption of electronic health records (EHRs) across the globe, and rising importance of evidence-based data from registries for effectiveness, safety and quality, the market […]Read More..
With the arrival of the industrial revolution, life sciences industry embarks the new phase of transformation in technologies. Growing strategic alliances, advancements in technologies, and progress in the availability of useful tools have significantly impacted various sectors of life sciences such as pharmaceutical, biotech, and healthcare. As per the recent research by Meticulous Research, the life […]Read More..
The global antimicrobial susceptibility testing market is expected to grow at a CAGR of around 6.1% from 2019 to 2027 to reach at $5.09 billion by 2027. Susceptibility testing is used in the determination of the antimicrobials inhibiting the growth of the bacteria or fungi causing a specific infection. The aim of antimicrobial susceptibility testing […]Read More..
The Global Flow Cytometry Market is expected to grow at a CAGR of 8.2% from 2019 to 2027 to reach at $6.36 billion by 2027. Flow cytometry is a widely used method for analyzing cell size & volume, assessing the purity of isolated subpopulations, characterizing & defining different cell types in a heterogeneous cell population, […]Read More..
The clinical trial materials and supplies market is expected to grow at a CAGR of 6% from 2019 to reach $25.9 billion by 2025. Clinical trials have a vigorous supply chain management of the drugs considering the stringency of the regulations and the availability of the infrastructure for the efficient execution. The drug manufacturers and […]Read More..